In the
bio-tech market, the
RTX Corporation continues to carve out its position, evidenced by various recent happenings. Its potential as a low-risk, long-term upside trade for as far ahead as 2025 has been highlighted while its upgraded status by Deutsche Bank from 'Hold' to 'Buy' underscored its strong market position. The corporation has received numerous contracts to boost its influence and reach with highlights including a
$946 million contract to provide additional Patriot Air Defense Systems to Romania and a
$1.2 billion contract to provide similar systems to Germany. Their innovative to the defense sector,
Raytheon Lower Tier Air and Missile Defense Sensor, has shown impressive results in live fire tests. Notably, their shares have seen a nice lift -- up 37% Year To Date, according to market observer Jim Cramer. Unfortunately, it's not all positive as RTX Corporation was embroiled in a
bribery and fraud scandal that saw the company agree to pay over $950 million in fines. Despite these challenges, growth continues to be noticed with several analysts appearing bullish on the corporation's stock.
Rtx Corporation RTX News Analytics from Thu, 21 Mar 2024 07:00:00 GMT to Sat, 04 Jan 2025 00:53:00 GMT -
Innovation 5
- Information 7
- Rumor -3
